Purchasing Research from or for the NHS?

por Smyth, J F
Publicado 1994

Small intestinal mucosal toxicity of cis-platinum--comparison of toxicity with platinum analogues and dexamethasone.

por Allan, S. G., Smyth, J. F.
Publicado 1986

Adenosine deaminase activity in leukaemia.

por Smyth, J. F., Harrap, K. R.
Publicado 1975

Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505.

por Meikle, I., Cummings, J., Macpherson, J. S., Smyth, J. F.
Publicado 1996

Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.

por Fergusson, R. J., Anderson, L. E., Macpherson, J. S., Robins, P., Smyth, J. F.
Publicado 1988

A prognostic model for ovarian cancer

por Clark, T G, Stewart, M E, Altman, D G, Gabra, H, Smyth, J F
Publicado 2001

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)

por Sewell, J M, Macleod, K G, Ritchie, A, Smyth, J F, Langdon, S P
Publicado 2002

12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cells.

por Rabiasz, G. J., Langdon, S. P., Anderson, L., Ritchie, A. A., Miller, W. R., Smyth, J. F.
Publicado 1992

Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.

por Jones, D. A., Cummings, J., Langdon, S. P., Maclellan, A. J., Higgins, T., Rozengurt, E., Smyth, J. F.
Publicado 1996

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

por Bartlett, J. M., Rabiasz, G. J., Scott, W. N., Langdon, S. P., Smyth, J. F., Miller, W. R.
Publicado 1992

[Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6–11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism

por MacKinnon, A C, Armstrong, R A, Waters, C M, Cummings, J, Smyth, J F, Haslett, C, Sethi, T
Publicado 1999

Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.

por Jodrell, D. I., Bowman, A., Stewart, M., Dunlop, N., French, R., MacLellan, A., Cummings, J., Smyth, J. F.
Publicado 1998

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines

por Wilson, K E, Bartlett, J M S, Miller, E P, Smyth, J F, Mullen, P, Miller, W R, Langdon, S P
Publicado 1999

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

por McPhillips, F, Mullen, P, Monia, B P, Ritchie, A A, Dorr, F A, Smyth, J F, Langdon, S P
Publicado 2001

Prognostic factors for survival in soft tissue sarcoma.

por el-Jabbour, J. N., Akhtar, S. S., Kerr, G. R., McLaren, K. M., Smyth, J. F., Rodger, A., Leonard, R. C.
Publicado 1990

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study

por Cameron, D A, Cornbleet, M C, Mackie, R M, Hunter, J A A, Gore, M, Hancock, B, Smyth, J F
Publicado 2001

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines.

por Langdon, S. P., Hawkes, M. M., Lawrie, S. S., Hawkins, R. A., Tesdale, A. L., Crew, A. J., Miller, W. R., Smyth, J. F.
Publicado 1990

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

por Gabra, H., Taylor, L., Cohen, B. B., Lessels, A., Eccles, D. M., Leonard, R. C., Smyth, J. F., Steel, C. M.
Publicado 1995

Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.

por Rabiasz, G. J., Langdon, S. P., Bartlett, J. M., Crew, A. J., Miller, E. P., Scott, W. N., Smyth, J. F., Miller, W. R.
Publicado 1992

Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.

por Sternberg, C. N., ten Bokkel Huinink, W. W., Smyth, J. F., Bruntsch, V., Dirix, L. Y., Pavlidis, N. A., Franklin, H., Wanders, S., Le Bail, N., Kaye, S. B.
Publicado 1994